Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.
alcohol-associated liver disease
cytochrome P450 2E1
drug-induced liver injury
mitochondria
nonalcoholic fatty liver disease
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
15 01 2022
15 01 2022
Historique:
received:
09
12
2021
revised:
05
01
2022
accepted:
11
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Cytochrome P450 2E1 (CYP2E1) is pivotal in hepatotoxicity induced by alcohol abuse and different xenobiotics. In this setting, CYP2E1 generates reactive metabolites inducing oxidative stress, mitochondrial dysfunction and cell death. In addition, this enzyme appears to play a role in the progression of obesity-related fatty liver to nonalcoholic steatohepatitis. Indeed, increased CYP2E1 activity in nonalcoholic fatty liver disease (NAFLD) is deemed to induce reactive oxygen species overproduction, which in turn triggers oxidative stress, necroinflammation and fibrosis. In 1997, Avadhani's group reported for the first time the presence of CYP2E1 in rat liver mitochondria, and subsequent investigations by other groups confirmed that mitochondrial CYP2E1 (mtCYP2E1) could be found in different experimental models. In this review, we first recall the main features of CYP2E1 including its role in the biotransformation of endogenous and exogenous molecules, the regulation of its expression and activity and its involvement in different liver diseases. Then, we present the current knowledge on the physiological role of mtCYP2E1, its contribution to xenobiotic biotransformation as well as the mechanism and regulation of CYP2E1 targeting to mitochondria. Finally, we discuss experimental investigations suggesting that mtCYP2E1 could have a role in alcohol-associated liver disease, xenobiotic-induced hepatotoxicity and NAFLD.
Identifiants
pubmed: 35053404
pii: cells11020288
doi: 10.3390/cells11020288
pmc: PMC8774478
pii:
doi:
Substances chimiques
Xenobiotics
0
Cytochrome P-450 CYP2E1
EC 1.14.13.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM130457
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : European Union
ID : GOLIATH N°825489
Références
Nature. 2020 Nov;587(7832):98-102
pubmed: 33116305
Mutat Res. 2005 Jan 6;569(1-2):101-10
pubmed: 15603755
Toxicol Lett. 2003 Sep 15;144(1):93-103
pubmed: 12919727
Patholog Res Int. 2012;2012:172894
pubmed: 22666632
Toxicology. 2015 Dec 2;338:47-58
pubmed: 26463279
J Hepatol. 2013 Feb;58(2):395-8
pubmed: 22940046
Food Chem Toxicol. 1999 Apr;37(4):423-53
pubmed: 10418958
Eur J Pharmacol. 1993 Jun 1;248(1):7-14
pubmed: 8339754
Oxid Med Cell Longev. 2018 Jul 26;2018:4396403
pubmed: 30147834
Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94
pubmed: 22980195
Arch Toxicol. 2018 Oct;92(10):3077-3091
pubmed: 30151596
Toxicol Res (Camb). 2017;6(3):273-289
pubmed: 28989700
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Sep;1862(9):869-882
pubmed: 28483554
Sci Rep. 2017 Jan 04;7:39764
pubmed: 28051126
Cell Metab. 2015 May 5;21(5):739-46
pubmed: 25955209
Int J Mol Sci. 2021 Feb 26;22(5):
pubmed: 33652942
Lab Invest. 2012 Mar;92(3):396-410
pubmed: 22157718
Biochem Pharmacol. 2010 Nov 15;80(10):1592-600
pubmed: 20723539
Int J Toxicol. 2012 Nov-Dec;31(6):551-63
pubmed: 23197488
Antioxidants (Basel). 2018 Jul 30;7(8):
pubmed: 30061536
Toxicol In Vitro. 2013 Jun;27(4):1267-76
pubmed: 23470418
Biochem Biophys Res Commun. 1993 Feb 15;190(3):780-5
pubmed: 8439329
Toxicol Appl Pharmacol. 2006 Oct 15;216(2):309-18
pubmed: 16843508
Pestic Biochem Physiol. 2021 Oct;178:104944
pubmed: 34446210
Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):630-7
pubmed: 21664213
Chem Biol Interact. 2020 May 1;322:109056
pubmed: 32198084
Biochem Pharmacol. 2014 Jul 15;90(2):145-58
pubmed: 24794636
Nat Metab. 2019 Apr;1(4):422-430
pubmed: 32694878
Toxicol Lett. 2016 Sep 30;259:87-94
pubmed: 27491884
Chem Biol Interact. 2020 Jan 25;316:108918
pubmed: 31836462
J Lipid Res. 1999 Nov;40(11):1990-7
pubmed: 10553002
J Biol Chem. 2002 Nov 29;277(48):45904-10
pubmed: 12270935
Sci Total Environ. 2022 Feb 1;806(Pt 2):150703
pubmed: 34600989
J Nutr. 2011 Apr 1;141(4):603-10
pubmed: 21346097
J Biol Chem. 2006 Feb 24;281(8):5128-36
pubmed: 16380384
Hepatology. 2013 Oct;58(4):1497-507
pubmed: 23299992
Pharmacol Ther. 1995;67(1):101-54
pubmed: 7494860
J Biol Chem. 2001 Jul 6;276(27):24680-9
pubmed: 11325963
FEBS Lett. 2005 Dec 19;579(30):6895-902
pubmed: 16337197
Life Sci. 2021 Aug 1;278:119648
pubmed: 34043994
Br J Pharmacol. 2008 Feb;153(4):784-91
pubmed: 18071298
J Appl Toxicol. 2021 Oct 3;:
pubmed: 34601724
Hepatology. 1991 Apr;13(4):722-7
pubmed: 2010167
Biomed Pharmacother. 2008 Nov;62(9):567-72
pubmed: 17418998
Drug Metab Dispos. 2007 Jan;35(1):1-8
pubmed: 17020953
Arch Pharm Res. 2000 Aug;23(4):267-82
pubmed: 10976571
Biomark Med. 2016 Nov;10(11):1141-1151
pubmed: 27611762
FASEB J. 2018 Jun;32(6):3278-3288
pubmed: 29401608
J Biol Chem. 2002 Oct 25;277(43):40583-93
pubmed: 12191992
United European Gastroenterol J. 2021 Apr;9(3):332-342
pubmed: 33887125
Semin Liver Dis. 2019 May;39(2):221-234
pubmed: 30849782
J Biol Chem. 2010 Jul 16;285(29):22282-90
pubmed: 20463018
Toxicol Appl Pharmacol. 2016 Feb 1;292:40-55
pubmed: 26739624
J Intern Med. 2016 May;279(5):485-93
pubmed: 26728692
Biomolecules. 2020 Oct 11;10(10):
pubmed: 33050657
Alcohol Clin Exp Res. 2007 Oct;31(10):1660-8
pubmed: 17681033
Hum Exp Toxicol. 2013 Nov;32(11):1213-27
pubmed: 23424210
Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1231-51
pubmed: 20629582
J Biol Chem. 2013 May 3;288(18):12627-44
pubmed: 23471973
Hepatology. 2003 Oct;38(4):999-1007
pubmed: 14512887
Arch Biochem Biophys. 1997 Mar 1;339(1):136-50
pubmed: 9056243
Toxicol In Vitro. 2011 Mar;25(2):475-84
pubmed: 21130154
Acta Pharmacol Sin. 2016 Apr;37(4):561-70
pubmed: 26838075
JHEP Rep. 2021 May 11;3(4):100305
pubmed: 34189448
Curr Pharm Des. 2018;24(14):1502-1517
pubmed: 29637855
J Biol Chem. 2011 Mar 18;286(11):9443-56
pubmed: 21209460
J Pharmacol Exp Ther. 1993 Feb;264(2):944-50
pubmed: 8437134
Diabetes. 2004 Jan;53(1):185-94
pubmed: 14693714
FEBS Lett. 1999 Oct 29;460(2):309-14
pubmed: 10544255
Diabetes. 2013 Feb;62(2):519-30
pubmed: 23043159
Eur J Pharm Sci. 2015 Jun 20;73:49-56
pubmed: 25840124
Bioessays. 1990 Sep;12(9):429-35
pubmed: 2256907
Redox Biol. 2014;2:1048-54
pubmed: 25454746
Food Chem Toxicol. 2016 Apr;90:1-9
pubmed: 26806632
FEBS J. 2011 Nov;278(22):4252-60
pubmed: 21929725
Toxicol In Vitro. 2020 Aug;66:104842
pubmed: 32283135
Mol Pharmacol. 2007 Jul;72(1):173-81
pubmed: 17440116
Gastroenterology. 2018 Sep;155(3):629-647
pubmed: 30012333
Hepatol Commun. 2020 Sep 01;4(11):1610-1623
pubmed: 33163832
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101470
pubmed: 32571750
Cell Death Dis. 2021 Jan 12;12(1):76
pubmed: 33436540
J Biol Chem. 2010 Aug 6;285(32):24609-19
pubmed: 20529841
Immunopharmacol Immunotoxicol. 2021 Oct;43(5):527-535
pubmed: 34282716
Drug Metab Rev. 2019 May;51(2):178-195
pubmed: 31203697
Hepatology. 2006 Apr;43(4):817-25
pubmed: 16557553
FASEB J. 1992 Jan 6;6(2):724-30
pubmed: 1537462
Biology (Basel). 2020 Nov 26;9(12):
pubmed: 33255949
Toxicology. 2017 Mar 1;378:114-124
pubmed: 28082109
Exp Cell Res. 1998 Jul 10;242(1):294-302
pubmed: 9665827
Antioxid Redox Signal. 2012 Nov 15;17(10):1351-61
pubmed: 22490042
World J Gastroenterol. 2007 Oct 7;13(37):4931-7
pubmed: 17854134
Food Chem Toxicol. 2020 Jan;135:110916
pubmed: 31669601
Biochem Pharmacol. 2003 Nov 15;66(10):2011-20
pubmed: 14599559
J Pharmacol Exp Ther. 2015 Jan;352(1):77-89
pubmed: 25347994
Environ Sci Pollut Res Int. 2017 Nov;24(32):24916-24927
pubmed: 28918601
JAMA. 2021 Jul 13;326(2):165-176
pubmed: 34255003
Xenobiotica. 2018 Sep;48(9):867-881
pubmed: 28882082
Int J Mol Sci. 2021 Jul 30;22(15):
pubmed: 34360999
J Pharmacol Exp Ther. 2015 Jan;352(1):139-47
pubmed: 25362106